Zhe-Sheng Chen (Zhesheng Chen)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 106

Top Venues

Signal transduction and targeted therapy

Molecular cancer

Cancers

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

St. John's University

Kagoshima University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

St. John's University Sep 01 2004

United States

Professor :: Pharmaceutical Sciences

Education History

Kagoshima University Apr 01 1994 - Mar 25 1998

Japan

PHD :: Institute for Cancer Research

Sun Yat-Sen University

China

MSC :: Public Health

Guangdong Pharmaceutical University Sep 10 1980 - Jul 29 1985

China

PHD

Publications

Jianyou Gu, Wenying Zhang, Xianxing Wang, Qiang Zhou, Junfeng Zhang, Fuming Xie, Renpei Xia, Zhe-Sheng Chen, Huaizhi Wang
Bridging cultures: Chinese elements in scientific illustrations. Chinese medicine 19 (1) (2024)
Jianyou Gu, Wenying Zhang, Xianxing Wang, Qiang Zhou, Junfeng Zhang, Fuming Xie, Renpei Xia, Zhe-Sheng Chen, Huaizhi Wang
Correction: Bridging cultures: Chinese elements in scientific illustrations. Chinese medicine 19 (1) (2024)
Shiwen Huo, Jinqi Xue, Shuo Wang, Huilian Shan, Guanglei Chen, Nan Niu, Yimin Wang, Fang Qiu, Yi Zhao, Fei Xing, Xinyu Zheng, Wei Tu, Ke Li, Hai Zhao, Meiyue Tang, Qianshi Xu, Chao Liu, Yafei Zhao, Xiaofan Jiang, Zheng Pang, Keliang Zhang, Dianlong Zhang, Zhe-Sheng Chen, Caigang Liu
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer. MedComm 5 (3) (2024)
Ying-Ying Xiao, Luo-Xing Xia, Wen-Jing Jiang, Jian-Feng Qin, Li-Xin Zhao, Zhan Li, Li-Juan Huang, Ke-Xin Li, Peng-Jiu Yu, Li Wei, Xue-Yan Jiang, Zhe-Sheng Chen, Xi-Yong Yu
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis. Cell proliferation 57 (5) (2024)
Jianyou Gu, Wenying Zhang, Xianxing Wang, Qiang Zhou, Junfeng Zhang, Fuming Xie, Renpei Xia, Zhe-Sheng Chen, Huaizhi Wang
Bridging cultures: Chinese elements in scientific illustrations. Chinese medicine 19 (1) (2024)
Xing-Duo Dong, Qisi Lu, Yi-Dong Li, Chao-Yun Cai, Qiu-Xu Teng, Zi-Ning Lei, Zeng-Hui Wei, Fan Yin, Leli Zeng, Zhe-Sheng Chen
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. Journal of translational internal medicine 12 (3) (2024)
Ying-Ying Xiao, Luo-Xing Xia, Wen-Jing Jiang, Jian-Feng Qin, Li-Xin Zhao, Zhan Li, Li-Juan Huang, Ke-Xin Li, Peng-Jiu Yu, Li Wei, Xue-Yan Jiang, Zhe-Sheng Chen, Xi-Yong Yu
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis. Cell proliferation (2024)
Harsh Patel, Jiaxin Li, Letao Bo, Riddhi Mehta, Charles R Ashby, Shanzhi Wang, Wei Cai, Zhe-Sheng Chen
Nanotechnology-based delivery systems to overcome drug resistance in cancer. Medical review (2021) 4 (1) (2024)
Ying-Ying Xiao, Luo-Xing Xia, Wen-Jing Jiang, Jian-Feng Qin, Li-Xin Zhao, Zhan Li, Li-Juan Huang, Ke-Xin Li, Peng-Jiu Yu, Li Wei, Xue-Yan Jiang, Zhe-Sheng Chen, Xi-Yong Yu
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis. Cell proliferation 57 (5) (2024)
Jianyou Gu, Wenying Zhang, Xianxing Wang, Qiang Zhou, Junfeng Zhang, Fuming Xie, Renpei Xia, Zhe-Sheng Chen, Huaizhi Wang
Correction: Bridging cultures: Chinese elements in scientific illustrations. Chinese medicine 19 (1) (2024)
Harsh Patel, Jiaxin Li, Letao Bo, Riddhi Mehta, Charles R Ashby, Shanzhi Wang, Wei Cai, Zhe-Sheng Chen
Nanotechnology-based delivery systems to overcome drug resistance in cancer. Medical review (2021) 4 (1) (2024)
Yunali Ashar, Qiuxu Teng, John N D Wurpel, Zhe-Sheng Chen, Sandra E Reznik
RETRACTED: Ashar et al. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 2022, 12 , 1162. Biomolecules 14 (4) (2024)
Jun Liao, Yi Li, Li Fan, Yuhan Sun, Zhengyan Gu, Qing-Qiang Xu, Yun Wang, Liyan Xiong, Kai Xiao, Zhe-Sheng Chen, Zhiwei Ma, Chuan Zhang, Tingfang Wang, Ying Lu
Bioactive Ceria Nanoenzymes Target Mitochondria in Reperfusion Injury to Treat Ischemic Stroke. ACS nano (2024)
Yunali Ashar, Qiuxu Teng, John N D Wurpel, Zhe-Sheng Chen, Sandra E Reznik
RETRACTED: Ashar et al. Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 2022, 12 , 1162. Biomolecules 14 (4) (2024)
Jianyou Gu, Wenying Zhang, Xianxing Wang, Qiang Zhou, Junfeng Zhang, Fuming Xie, Renpei Xia, Zhe-Sheng Chen, Huaizhi Wang
Bridging cultures: Chinese elements in scientific illustrations. Chinese medicine 19 (1) (2024)
Shiwen Huo, Jinqi Xue, Shuo Wang, Huilian Shan, Guanglei Chen, Nan Niu, Yimin Wang, Fang Qiu, Yi Zhao, Fei Xing, Xinyu Zheng, Wei Tu, Ke Li, Hai Zhao, Meiyue Tang, Qianshi Xu, Chao Liu, Yafei Zhao, Xiaofan Jiang, Zheng Pang, Keliang Zhang, Dianlong Zhang, Zhe-Sheng Chen, Caigang Liu
A pilot trial of neoadjuvant pyrotinib plus trastuzumab, dalpiciclib, and letrozole for triple-positive breast cancer. MedComm 5 (3) (2024)
Ying-Ying Xiao, Luo-Xing Xia, Wen-Jing Jiang, Jian-Feng Qin, Li-Xin Zhao, Zhan Li, Li-Juan Huang, Ke-Xin Li, Peng-Jiu Yu, Li Wei, Xue-Yan Jiang, Zhe-Sheng Chen, Xi-Yong Yu
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis. Cell proliferation 57 (5) (2024)
Xing-Duo Dong, Qisi Lu, Yi-Dong Li, Chao-Yun Cai, Qiu-Xu Teng, Zi-Ning Lei, Zeng-Hui Wei, Fan Yin, Leli Zeng, Zhe-Sheng Chen
RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells. Journal of translational internal medicine 12 (3) (2024)
Ying-Ying Xiao, Luo-Xing Xia, Wen-Jing Jiang, Jian-Feng Qin, Li-Xin Zhao, Zhan Li, Li-Juan Huang, Ke-Xin Li, Peng-Jiu Yu, Li Wei, Xue-Yan Jiang, Zhe-Sheng Chen, Xi-Yong Yu
Cardiopulmonary progenitors facilitate cardiac repair via exosomal transfer of miR-27b-3p targeting the SIK1-CREB1 axis. Cell proliferation 57 (5) (2024)
Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, Yang Dong, Lin Hao, Jia-Xin Qin, Wei Wang, Zhe-Sheng Chen, Cong-Hui Han
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal transduction and targeted therapy 8 (1) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Fei Cao, Yulong Li, Furong Ma, Zumei Wu, Zheshen Li, Zhe-Sheng Chen, Xiangdong Cheng, Jiang-Jiang Qin, Jinyun Dong
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance. RSC medicinal chemistry 15 (2) (2023)
Fei Cao, Yulong Li, Furong Ma, Zumei Wu, Zheshen Li, Zhe-Sheng Chen, Xiangdong Cheng, Jiang-Jiang Qin, Jinyun Dong
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance. RSC medicinal chemistry 15 (2) (2023)
Longyang Liu, Chunlin Chen, Ping Liu, Jing Li, Zhanjun Pang, Jiayu Zhu, Zhongqiu Lin, Haixu Zhou, Yingying Xie, Tiancai Lan, Zhe-Sheng Chen, Zhaoyang Zeng, Weiyi Fang
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Dong-Mei Zhang, Chang Shu, Jun-Jiang Chen, Kamlesh Sodani, Jiao Wang, Jaya Bhatnagar, Ping Lan, Zhi-Xiong Ruan, Zhi-Jie Xiao, Suresh V Ambudkar, Wei-Min Chen, Zhe-Sheng Chen, Wen-Cai Ye
Correction to "BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo ". Molecular pharmaceutics (2023)
Luqi Cao, Yuhao Xie, Zhe-Sheng Chen, Charles R Ashby
A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: A pivotal breakthrough. Journal of translational internal medicine 11 (2) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Zhicheng Xiao, Yi Li, Liyan Xiong, Jun Liao, Yijun Gao, Yunchun Luo, Yun Wang, Ting Chen, Dahai Yu, Tingfang Wang, Chuan Zhang, Zhe-Sheng Chen
Recent Advances in Anti-Atherosclerosis and Potential Therapeutic Targets for Nanomaterial-Derived Drug Formulations. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Xing Liu, Gao-Chuan Fang, Hao Lu, Zhen-Duo Shi, Zhe-Sheng Chen, Cong-Hui Han
Lutetium Lu 177 vipivotide tetraxetan for prostate cancer. Drugs of today (Barcelona, Spain : 1998) 59 (1) (2023)
Zi-Ning Lei, Qin Tian, Qiu-Xu Teng, John N D Wurpel, Leli Zeng, Yihang Pan, Zhe-Sheng Chen
Understanding and targeting resistance mechanisms in cancer. MedComm 4 (3) (2023)
Xin Peng, Yingying Wang, Shaolu Zhang, Zhennan Tao, Yuxiang Dai, Francois X Claret, Moshe Elkabets, Hou-Wen Lin, Zhe-Sheng Chen, Dexin Kong
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair. Signal transduction and targeted therapy 8 (1) (2023)
Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, Yang Dong, Lin Hao, Jia-Xin Qin, Wei Wang, Zhe-Sheng Chen, Cong-Hui Han
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal transduction and targeted therapy 8 (1) (2023)
Xinnan Li, Xiaotong Ze, Shengnan Zhou, Zhaoxin Hu, Chen He, Yilin Jia, Lihua Liu, Tao Wang, Junda Li, Shengtao Xu, Dong-Hua Yang, Zhe-Sheng Chen, Hequan Yao, Jinyi Xu, Hong Yao
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase. Journal of medicinal chemistry (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Zhijian Wang, Yuhao Xie, Jing-Quan Wang, Yuanhui Cheng, Joshua Fleishman, Zhe-Sheng Chen, Yun Chen
Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma. Drugs of today (Barcelona, Spain : 1998) 59 (3) (2023)
Zhen-Duo Shi, Kun Pang, Zhuo-Xun Wu, Yang Dong, Lin Hao, Jia-Xin Qin, Wei Wang, Zhe-Sheng Chen, Cong-Hui Han
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal transduction and targeted therapy 8 (1) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Xin Peng, Yingying Wang, Shaolu Zhang, Zhennan Tao, Yuxiang Dai, Francois X Claret, Moshe Elkabets, Hou-Wen Lin, Zhe-Sheng Chen, Dexin Kong
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair. Signal transduction and targeted therapy 8 (1) (2023)
Lu Liang, Wenyan Xu, Ao Shen, Xiaomei Fu, Huiyu Cen, Siran Wang, Zhongxiao Lin, Lingmin Zhang, Fangyu Lin, Xin Zhang, Na Zhou, Jishuo Chang, Zhe-Sheng Chen, Chuwen Li, Xiyong Yu
Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization. MedComm 4 (3) (2023)
Letao Bo, Youyou Wang, Yidong Li, John N D Wurpel, Zoufang Huang, Zhe-Sheng Chen
The Battlefield of Chemotherapy in Pediatric Cancers. Cancers 15 (7) (2023)
Xin Peng, Yingying Wang, Shaolu Zhang, Zhennan Tao, Yuxiang Dai, Francois X Claret, Moshe Elkabets, Hou-Wen Lin, Zhe-Sheng Chen, Dexin Kong
Stellettin B renders glioblastoma vulnerable to poly (ADP-ribose) polymerase inhibitors via suppressing homology-directed repair. Signal transduction and targeted therapy 8 (1) (2023)
Sheng-Xiong Zhang, Wen Tian, Yuan-Liang Liu, Jia-Hui Ni, Dan Zhang, Hua-Feng Pan, Zi-Ming Zhao, Bo Ai, Zhe-Sheng Chen, Li-Zhu Lin, Wei Liu
Mechanism of N-Methyl-N-Nitroso-Urea-Induced Gastric Precancerous Lesions in Mice. Journal of oncology 2022 (2022)
Yu-Zhong Yu, Dao-Jun Lv, Chong Wang, Xian-Lu Song, Tao Xie, Tao Wang, Zhi-Min Li, Jia-Ding Guo, Du-Jiang Fu, Kang-Jin Li, Ding-Lan Wu, Franky Leung Chan, Ning-Han Feng, Zhe-Sheng Chen, Shan-Chao Zhao
Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Molecular cancer 21 (1) (2022)
Liwu Fu, Zhe-Sheng Chen
Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure. Signal transduction and targeted therapy 7 (1) (2022)
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe-Sheng Chen, Yulong He
Signaling pathways and therapeutic interventions in gastric cancer. Signal transduction and targeted therapy 7 (1) (2022)
Li-Juan Deng, Wei-Qing Deng, Shu-Ran Fan, Min-Feng Chen, Ming Qi, Wen-Yu Lyu, Qi Qi, Amit K Tiwari, Jia-Xu Chen, Dong-Mei Zhang, Zhe-Sheng Chen
m6A modification: recent advances, anticancer targeted drug discovery and beyond. Molecular cancer 21 (1) (2022)
Vivek P Chavda, Suneetha Vuppu, Toshika Mishra, Sathvika Kamaraj, Aayushi B Patel, Nikita Sharma, Zhe-Sheng Chen
Recent review of COVID-19 management: diagnosis, treatment and vaccination. Pharmacological reports : PR 74 (6) (2022)
Fengwu Chen, Kaijian Hou, Zhe-Sheng Chen
Gut microbes regulate the feeding center: a new discovery of Gut Brain Axis. Signal transduction and targeted therapy 7 (1) (2022)
Zhiyong Ding, Nan Wang, Ning Ji, Zhe-Sheng Chen
Proteomics technologies for cancer liquid biopsies. Molecular cancer 21 (1) (2022)
Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Xiaoming Xie
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Huajian Zhu, Yuchen Tan, Chen He, Yang Liu, Yiping Duan, Wenjian Zhu, Tiandong Zheng, Da-Hong Li, Jinyi Xu, Dong-Hua Yang, Zhe-Sheng Chen, Shengtao Xu
Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects. Journal of medicinal chemistry 65 (16) (2022)
Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Xiaoming Xie
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Yuhao Xie, Qisi Lu, Jing-Quan Wang, Letao Bo, Charles R Ashby, Zhe-Sheng Chen
Amivantamab: a monoclonal EGFR-MET bispecific antibody for EGFR exon 20 insertion in non-small cell lung cancer. Drugs of today (Barcelona, Spain : 1998) 58 (8) (2022)
Qiurong Yang, Jing Xu, Jianmei Gu, Hui Shi, Jiayin Zhang, Jianye Zhang, Zhe-Sheng Chen, Xinjian Fang, Taofeng Zhu, Xu Zhang
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2022)
Yuqi Yang, Qiu-Xu Teng, Zhuo-Xun Wu, Jing-Quan Wang, Zi-Ning Lei, Sabrina Lusvarghi, Suresh V Ambudkar, Ning Ji, Zhe-Sheng Chen
PBK/TOPK inhibitor OTS964 resistance is mediated by ABCB1-dependent transport function in cancer: in vitro and in vivo study. Molecular cancer 21 (1) (2022)
Xiaodan Chong, Jingde Chen, Nanxin Zheng, Zhuqing Zhou, Yanan Hai, Shiqing Chen, Yu Zhang, Qingzhuo Yu, Shijun Yu, Zhiqin Chen, Wenfang Bao, Ming Quan, Zhe-Sheng Chen, Yangyang Zhan, Yong Gao
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN. Molecular cancer 21 (1) (2022)
Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Xiaoming Xie
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Kun Pang, Wei Wang, Jia-Xin Qin, Zhen-Duo Shi, Lin Hao, Yu-Yang Ma, Hao Xu, Zhuo-Xun Wu, Deng Pan, Zhe-Sheng Chen, Cong-Hui Han
Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. MedComm 3 (4) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Huibin Song, Dongcheng Liu, Lingwei Wang, Kaisheng Liu, Chen Chen, Le Wang, Yi Ren, Bing Ju, Fuhua Zhong, Xingyu Jiang, Guangsuo Wang, Zhe-Sheng Chen, Chang Zou
Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma. Molecular cancer 21 (1) (2022)
Mengjie Zhao, Yu Duan, Jiangyun Wang, Yong Liu, Yao Zhao, Haihua Wang, Lei Zhang, Zhe-Sheng Chen, Zhenbo Hu, Liuya Wei
Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with t (8; 21) or MLL Gene Translocation and Leukemic Stem-Like Cells. Journal of oncology 2022 (2022)
Bingrui Liu, Rongyu Liu, Qifeng Liu, Charles R Ashby, Hang Zhang, Zhe-Sheng Chen
The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review. Medicinal research reviews 42 (5) (2022)
Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Xiaoming Xie
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (5) (2022)
Yutian Zou, Feng Ye, Yanan Kong, Xiaoqian Hu, Xinpei Deng, Jindong Xie, Cailu Song, Xueqi Ou, Song Wu, Linyu Wu, Yi Xie, Wenwen Tian, Yuhui Tang, Chau-Wei Wong, Zhe-Sheng Chen, Xinhua Xie, Xiaoming Xie
The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Vivek P Chavda, Feng-Feng Ping, Zhe-Sheng Chen
An Impact of COVID-19 on Cancer Care: An Update. Vaccines 10 (12) (2022)
Yunali Ashar, Qiuxu Teng, John N D Wurpel, Zhe-Sheng Chen, Sandra E Reznik
Palmitic Acid Impedes Extravillous Trophoblast Activity by Increasing MRP1 Expression and Function. Biomolecules 12 (8) (2022)
Yutian Zou, Shaoquan Zheng, Xinhua Xie, Feng Ye, Xiaoqian Hu, Zhi Tian, Shu-Mei Yan, Lu Yang, Yanan Kong, Yuhui Tang, Wenwen Tian, Jindong Xie, Xinpei Deng, Yan Zeng, Zhe-Sheng Chen, Xiaoming Xie, Xiaoming Xie
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature communications 13 (1) (2022)
Kaijian Hou, Zhuo-Xun Wu, Xuan-Yu Chen, Jing-Quan Wang, Dongya Zhang, Chuanxing Xiao, Dan Zhu, Jagadish B Koya, Liuya Wei, Jilin Li, Zhe-Sheng Chen
Microbiota in health and diseases. Signal transduction and targeted therapy 7 (1) (2022)
Akanksha Patel, Aishwarya Saraswat, Harsh Patel, Zhe-Sheng Chen, Ketankumar Patel
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 15 (1) (2022)
Zhen-Duo Shi, Lin Hao, Xiao-Xiao Han, Zhuo-Xun Wu, Kun Pang, Yang Dong, Jia-Xin Qin, Guang-Yue Wang, Xuan-Ming Zhang, Tian Xia, Qing Liang, Yan Zhao, Rui Li, Shao-Qi Zhang, Jun-Hao Zhang, Jian-Gang Chen, Gong-Cheng Wang, Zhe-Sheng Chen, Cong-Hui Han
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Molecular cancer 21 (1) (2022)
Shengtao Xu, Hong Yao, Yangyi Qiu, Manzhen Zhou, Da-Hong Li, Liang Wu, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu
Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer. Journal of medicinal chemistry 64 (23) (2021)
Shaowen Xie, Yuan Sun, Yulin Liu, Xinnan Li, Xinuo Li, Wenyi Zhong, Feiyan Zhan, Jingjie Zhu, Hong Yao, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu, Shengtao Xu
Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). Journal of medicinal chemistry 64 (13) (2021)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Zi-Ning Lei, Zhe-Sheng Chen, Xiao-Bing Chen, Hong-Min Liu, Bin Yu
Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. Journal of medicinal chemistry 64 (21) (2021)
Jing-Quan Wang, Zhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, Yi-Dong Li, Zi-Ning Lei, Khushboo A Jani, Neeraj Kaushal, Zhe-Sheng Chen
ATP-binding cassette (ABC) transporters in cancer: A review of recent updates. Journal of evidence-based medicine 14 (3) (2021)
Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Feng-Feng Ping, Peng Song, John N D Wurpel, Zhe-Sheng Chen
Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. MedComm 2 (4) (2021)
Shuo Yuan, Bo Wang, Qing-Qing Dai, Xiao-Nan Zhang, Jing-Ya Zhang, Jia-Hui Zuo, Hui Liu, Zhe-Sheng Chen, Guo-Bo Li, Shaomeng Wang, Hong-Min Liu, Bin Yu
Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors. Journal of medicinal chemistry 64 (19) (2021)
Harsh Patel, Zhuo-Xun Wu, Yanglu Chen, Letao Bo, Zhe-Sheng Chen
Drug resistance: from bacteria to cancer. Molecular biomedicine 2 (1) (2021)
Yixing Wu, Hongmei Zeng, Qing Yu, Huatian Huang, Beatrice Fervers, Zhe-Sheng Chen, Changquan Ling
A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Cancers 13 (11) (2021)
Silpa Narayanan, Ying-Fang Fan, Nehaben A Gujarati, Qiu-Xu Teng, Jing-Quan Wang, Chao-Yun Cai, Yuqi Yang, Anirudh J Chintalapati, Yixiong Lei, Vijaya L Korlipara, Zhe-Sheng Chen
VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study. Cancers 13 (18) (2021)
Jia Li, Leli Zeng, Zheng Wang, Hengxing Chen, Shuo Fang, Jinquan Wang, Chao-Yun Cai, Enming Xing, Xinxing Liao, Zhi-Wei Li, Charles R Ashby, Zhe-Sheng Chen, Hui Chao, Yihang Pan
Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers. Advanced materials (Deerfield Beach, Fla.) (2021)
Yunali V Ashar, Jingchun Zhou, Pranav Gupta, Qiu-Xu Teng, Zi-Ning Lei, Sandra E Reznik, Sabrina Lusvarghi, John Wurpel, Suresh V Ambudkar, Zhe-Sheng Chen
BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance. Cancers 12 (9) (2020)
Hang Zhang, Haiwei Xu, Charles R Ashby, Yehuda G Assaraf, Zhe-Sheng Chen, Hong-Min Liu
Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp). Medicinal research reviews 41 (1) (2020)
Lei Zhang, Yidong Li, Qianchao Wang, Zhuo Chen, Xiaoyun Li, Zhuoxun Wu, Chaohua Hu, Dan Liao, Wei Zhang, Zhe-Sheng Chen
The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer. Molecular cancer 19 (1) (2020)
Zhuo-Xun Wu, Yuqi Yang, Guangsuo Wang, Jing-Quan Wang, Qiu-Xu Teng, Lingling Sun, Zi-Ning Lei, Li-Zhu Lin, Zhe-Sheng Chen, Chang Zou
Dual TTK/CLK2 inhibitor, CC-671, selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells. Cancer science 111 (8) (2020)
Hong Yao, Shaowen Xie, Xiaoqian Ma, Junkai Liu, Hongyu Wu, Aijun Lin, Hequan Yao, Da-Hong Li, Shengtao Xu, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu
Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer. Journal of medicinal chemistry 63 (15) (2020)
Huibin Song, Dongcheng Liu, Shaowei Dong, Leli Zeng, Zhuoxun Wu, Pan Zhao, Litu Zhang, Zhe-Sheng Chen, Chang Zou
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications. Signal transduction and targeted therapy 5 (1) (2020)
Jingqiu Wang, Dong-Hua Yang, Yuqi Yang, Jing-Quan Wang, Chao-Yun Cai, Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Linguo Zhao, Zhe-Sheng Chen
Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells. International journal of molecular sciences 21 (4) (2020)
Yuqi Yang, Ning Ji, Chao-Yun Cai, Jing-Quan Wang, Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Qingbin Cui, Yihang Pan, Zhe-Sheng Chen
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor. Cancer communications (London, England) 40 (7) (2020)
Shuai Wang, Sai-Qi Wang, Qiu-Xu Teng, Linlin Yang, Zi-Ning Lei, Xiao-Han Yuan, Jun-Feng Huo, Xiao-Bing Chen, Mengru Wang, Bin Yu, Zhe-Sheng Chen, Hong-Min Liu
Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. Journal of medicinal chemistry 63 (24) (2020)
Guan-Nan Zhang, Pranav Gupta, Ming Wang, Anna Maria Barbuti, Charles R Ashby, Yun-Kai Zhang, Leli Zeng, Qiaobing Xu, Ying-Fang Fan, Zhe-Sheng Chen
Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo. Cancers 12 (2) (2020)
Kaisheng Liu, Lin Gao, Xiaoshi Ma, Juan-Juan Huang, Juan Chen, Leli Zeng, Charles R Ashby, Chang Zou, Zhe-Sheng Chen
Long non-coding RNAs regulate drug resistance in cancer. Molecular cancer 19 (1) (2020)
Zhuo-Xun Wu, Yuqi Yang, Qiu-Xu Teng, Jing-Quan Wang, Zi-Ning Lei, Jing-Qiu Wang, Sabrina Lusvarghi, Suresh V Ambudkar, Dong-Hua Yang, Zhe-Sheng Chen
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance. Cancers 12 (1) (2020)
Wenjing Wang, Mengyue Zhao, Lijuan Cui, Yong Ren, Jingyuan Zhang, Junli Chen, Lina Jia, Jiayu Zhang, Jingyu Yang, Guoliang Chen, Charles R Ashby, Chunfu Wu, Zhe-Sheng Chen, Lihui Wang
Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer. Molecular cancer 19 (1) (2020)
Xiaoshi Ma, Jinan Guo, Kaisheng Liu, Lipeng Chen, Dale Liu, Shaowei Dong, Jinquan Xia, Qiaoyun Long, Yongjian Yue, Pan Zhao, Fengyan Hu, Zhangang Xiao, Xinghua Pan, Kefeng Xiao, Zhiqiang Cheng, Zunfu Ke, Zhe-Sheng Chen, Chang Zou
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Molecular cancer 19 (1) (2020)
Kinsie E Arnst, Yuxi Wang, Zi-Ning Lei, Dong-Jin Hwang, Gyanendra Kumar, Dejian Ma, Deanna N Parke, Qiang Chen, Jinliang Yang, Stephen W White, Tiffany N Seagroves, Zhe-Sheng Chen, Duane D Miller, Wei Li
Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. Molecular pharmacology 96 (1) (2019)
Dan Liao, Wei Zhang, Pranav Gupta, Zi-Ning Lei, Jing-Quan Wang, Chao-Yun Cai, Albert A De Vera, Lei Zhang, Zhe-Sheng Chen, Dong-Hua Yang
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. Molecules (Basel, Switzerland) 24 (23) (2019)

Zhe-Sheng Chen.css-eqlu8i{font-size:small;padding-left:4px;} (Zhesheng Chen)

Publication Activity (10 Years)

Top Topics

Top Venues

Zhe-Sheng Chen (Zhesheng Chen)